165 related articles for article (PubMed ID: 17363907)
1. Treatment decision-making for patients with the Herlitz subtype of junctional epidermolysis bullosa.
Yan EG; Paris JJ; Ahluwalia J; Lane AT; Bruckner AL
J Perinatol; 2007 May; 27(5):307-11. PubMed ID: 17363907
[TBL] [Abstract][Full Text] [Related]
2. Long-term follow-up of patients with Herlitz-type junctional epidermolysis bullosa.
Yuen WY; Duipmans JC; Molenbuur B; Herpertz I; Mandema JM; Jonkman MF
Br J Dermatol; 2012 Aug; 167(2):374-82. PubMed ID: 22512697
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of epidermolysis bullosa in the antipodes: the Australasian Epidermolysis Bullosa Registry with a focus on Herlitz junctional epidermolysis bullosa.
Kho YC; Rhodes LM; Robertson SJ; Su J; Varigos G; Robertson I; Hogan P; Orchard D; Murrell DF
Arch Dermatol; 2010 Jun; 146(6):635-40. PubMed ID: 20566927
[TBL] [Abstract][Full Text] [Related]
4. Cause-specific risks of childhood death in inherited epidermolysis bullosa.
Fine JD; Johnson LB; Weiner M; Suchindran C
J Pediatr; 2008 Feb; 152(2):276-80. PubMed ID: 18206702
[TBL] [Abstract][Full Text] [Related]
5. Herlitz junctional epidermolysis bullosa.
Laimer M; Lanschuetzer CM; Diem A; Bauer JW
Dermatol Clin; 2010 Jan; 28(1):55-60. PubMed ID: 19945616
[TBL] [Abstract][Full Text] [Related]
6. Neonatal junctional epidermolysis bullosa: treatment conundrums and ethical decision making.
Yang CS; Kroshinksy D; Cummings BM
Am J Clin Dermatol; 2014 Oct; 15(5):445-50. PubMed ID: 25117154
[TBL] [Abstract][Full Text] [Related]
7. Treatment of two patients with Herlitz junctional epidermolysis bullosa with artificial skin bioequivalents.
Jiang QJ; Izakovic J; Zenker M; Fartasch M; Meneguzzi G; Rascher W; Schneider H
J Pediatr; 2002 Oct; 141(4):553-9. PubMed ID: 12378197
[TBL] [Abstract][Full Text] [Related]
8. Detection of novel LAMA3 mutation in Herlitz junctional epidermolysis bullosa in a Jordanian family.
Badran EF; Battah HA; Akl KF; Khalil RW; Al Amori I
Australas J Dermatol; 2013 Aug; 54(3):218-21. PubMed ID: 22963541
[TBL] [Abstract][Full Text] [Related]
9. Non-herlitz junctional epidermolysis bullosa.
Yancey KB; Hintner H
Dermatol Clin; 2010 Jan; 28(1):67-77. PubMed ID: 19945618
[TBL] [Abstract][Full Text] [Related]
10. Nephrotic syndrome and aberrant expression of laminin isoforms in glomerular basement membranes for an infant with Herlitz junctional epidermolysis bullosa.
Hata D; Miyazaki M; Seto S; Kadota E; Muso E; Takasu K; Nakano A; Tamai K; Uitto J; Nagata M; Moriyama K; Miyazaki K
Pediatrics; 2005 Oct; 116(4):e601-7. PubMed ID: 16147969
[TBL] [Abstract][Full Text] [Related]
11. Corrective gene transfer of keratinocytes from patients with junctional epidermolysis bullosa restores assembly of hemidesmosomes in reconstructed epithelia.
Vailly J; Gagnoux-Palacios L; Dell'Ambra E; Roméro C; Pinola M; Zambruno G; De Luca M; Ortonne JP; Meneguzzi G
Gene Ther; 1998 Oct; 5(10):1322-32. PubMed ID: 9930337
[TBL] [Abstract][Full Text] [Related]
12. Complete paternal uniparental isodisomy of chromosome 1 resulting in Herlitz junctional epidermolysis bullosa.
Fassihi H; Wessagowit V; Ashton GH; Moss C; Ward R; Denyer J; Mellerio JE; McGrath JA
Clin Exp Dermatol; 2005 Jan; 30(1):71-4. PubMed ID: 15663509
[TBL] [Abstract][Full Text] [Related]
13. [Junctional epidermolysis bullosa non-Herlitz with urethral affection].
Zappel K; Bruckner-Tuderman L; Müller D; Audring H; Kolde G; Biewald W; Blume-Peytavi U
J Dtsch Dermatol Ges; 2003 Jan; 1(1):50-6. PubMed ID: 16285293
[TBL] [Abstract][Full Text] [Related]
14. Adhesive stripping to remove epidermis in junctional epidermolysis bullosa for revertant cell therapy.
Gostynski A; Deviaene FC; Pasmooij AM; Pas HH; Jonkman MF
Br J Dermatol; 2009 Aug; 161(2):444-7. PubMed ID: 19416258
[TBL] [Abstract][Full Text] [Related]
15. Herlitz junctional epidermolysis bullosa: laminin-5 mutational profile and carrier frequency in the Italian population.
Castori M; Floriddia G; De Luca N; Pascucci M; Ghirri P; Boccaletti V; El Hachem M; Zambruno G; Castiglia D
Br J Dermatol; 2008 Jan; 158(1):38-44. PubMed ID: 17916201
[TBL] [Abstract][Full Text] [Related]
16. [Epidermolysis bullosa gravis Herlitz. A challenge for a pediatric department].
Moster D
Tidsskr Nor Laegeforen; 1991 Nov; 111(29):3499-501. PubMed ID: 1796434
[TBL] [Abstract][Full Text] [Related]
17. Increased risk of squamous cell carcinoma in junctional epidermolysis bullosa.
Mallipeddi R; Keane FM; McGrath JA; Mayou BJ; Eady RA
J Eur Acad Dermatol Venereol; 2004 Sep; 18(5):521-6. PubMed ID: 15324385
[TBL] [Abstract][Full Text] [Related]
18. Junctional epidermolysis bullosa incidence and survival: 5-year experience of the Dystrophic Epidermolysis Bullosa Research Association of America (DebRA) nurse educator, 2007 to 2011.
Kelly-Mancuso G; Kopelan B; Azizkhan RG; Lucky AW
Pediatr Dermatol; 2014; 31(2):159-62. PubMed ID: 23721227
[TBL] [Abstract][Full Text] [Related]
19. Ethical issues in end-of-life care.
Hinshaw DB
J Med Liban; 2008; 56(2):122-8. PubMed ID: 19534082
[TBL] [Abstract][Full Text] [Related]
20. Punch grafting of chronic ulcers in patients with laminin-332-deficient, non-Herlitz junctional epidermolysis bullosa.
Yuen WY; Huizinga J; Jonkman MF
J Am Acad Dermatol; 2013 Jan; 68(1):93-7, 97.e1-2. PubMed ID: 22633040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
